Spirometry is the most common type of test for examining lung function. It measures the volume and speed of air breathed in and out by the lungs. The spirometer is an essential tool in assessing conditions like asthma, cystic fibrosis, Chronic Obstructive Pulmonary Disorder (COPD) and pulmonary fibrosis. A spirogram can differentiate between two types of abnormal breathing patterns, restrictive and obstructive.
In persons suffering from restrictive lung disease (RLD), the expansion of the lungs is impaired when breathing in. This causes a decrease in lung volume, making it more difficult for the person to breathe, impairing both oxygenation and ventilation. One type of condition underlying RLD is pulmonary fibrosis. Pulmonary fibrosis is associated with scarring of the lungs, resulting in a honeycomb-like appearance. While rare, the disease is poorly understood and is frequently fatal.
Other disorders that fall under the umbrella of RLD include the autoimmune condition, sarcoidosis; myscular dystrophy, amyotrophic lateral sclerosis (ALS), and obesity. Most patients present initially with difficulty breathing. Sarcoidosis is recognized by red, swollen lesions known as granulomas, mostly affecting the lungs and the skin. Some patients may suddenly develop symptoms that disappear spontaneously. Other people may never know they have sarcoidosis until they have an x-ray for another condition.
Obstructive lung disease (OLD) is characterized by inflamed and obstructed airways. OLD obstructs airflow, leading to difficulty exhaling and frequent trips to the hospital. Bronchitis, asthma and COPD are examples of obstructive lung diseases. A common feature of OLD is loss of the ability to exhale 70 percent of breath within one second.
Asthma is caused by inflammation of the airways. One of the most common respiratory problems, it normally presents with wheezing, coughing and shortness of breath. Other, less frequent, symptoms, are fatigue, rapid breathing and sighing. Asthma can be life-threatening.
Cystic fibrosis (CF), a form of OLD, affects not only the lungs, but also the pancreas, intestine and liver. The most serious symptom is difficulty breathing. Advances in screening, diagnosis and treatment have resulted in a considerably improved prognosis for individuals with CF. In 1959, the the median age of survival was six months. By 2008, this had to risen to 37.5 years in the United States and, in Canada, from 24 to 47.7 in the years between 1982 and 2007. In Russia, where medical treatment is expensive and lung transplants are not performed, the median age of survival is 25 years of age.
The term COPD covers conditions like emphysema and chronic bronchitis. In emphysema, the delicate tissues lining the lungs become irreversibly damaged, most commonly from exposure to cigarette smoke. This limits the person's ability to exhale. While there is no cure for emphysema, smoking cessation will reduce disease progression.
Spirometry is an important diagnostic tool in respiratory medicine. Distinguishing between obstructive and restrictive conditions, it enables doctors to inform interventions and determine prognoses.
In persons suffering from restrictive lung disease (RLD), the expansion of the lungs is impaired when breathing in. This causes a decrease in lung volume, making it more difficult for the person to breathe, impairing both oxygenation and ventilation. One type of condition underlying RLD is pulmonary fibrosis. Pulmonary fibrosis is associated with scarring of the lungs, resulting in a honeycomb-like appearance. While rare, the disease is poorly understood and is frequently fatal.
Other disorders that fall under the umbrella of RLD include the autoimmune condition, sarcoidosis; myscular dystrophy, amyotrophic lateral sclerosis (ALS), and obesity. Most patients present initially with difficulty breathing. Sarcoidosis is recognized by red, swollen lesions known as granulomas, mostly affecting the lungs and the skin. Some patients may suddenly develop symptoms that disappear spontaneously. Other people may never know they have sarcoidosis until they have an x-ray for another condition.
Obstructive lung disease (OLD) is characterized by inflamed and obstructed airways. OLD obstructs airflow, leading to difficulty exhaling and frequent trips to the hospital. Bronchitis, asthma and COPD are examples of obstructive lung diseases. A common feature of OLD is loss of the ability to exhale 70 percent of breath within one second.
Asthma is caused by inflammation of the airways. One of the most common respiratory problems, it normally presents with wheezing, coughing and shortness of breath. Other, less frequent, symptoms, are fatigue, rapid breathing and sighing. Asthma can be life-threatening.
Cystic fibrosis (CF), a form of OLD, affects not only the lungs, but also the pancreas, intestine and liver. The most serious symptom is difficulty breathing. Advances in screening, diagnosis and treatment have resulted in a considerably improved prognosis for individuals with CF. In 1959, the the median age of survival was six months. By 2008, this had to risen to 37.5 years in the United States and, in Canada, from 24 to 47.7 in the years between 1982 and 2007. In Russia, where medical treatment is expensive and lung transplants are not performed, the median age of survival is 25 years of age.
The term COPD covers conditions like emphysema and chronic bronchitis. In emphysema, the delicate tissues lining the lungs become irreversibly damaged, most commonly from exposure to cigarette smoke. This limits the person's ability to exhale. While there is no cure for emphysema, smoking cessation will reduce disease progression.
Spirometry is an important diagnostic tool in respiratory medicine. Distinguishing between obstructive and restrictive conditions, it enables doctors to inform interventions and determine prognoses.
About the Author:
You can visit www.henanmedical.com for more helpful information about The Place Of The Spirometer In Diagnosing Lung Conditions.
Aucun commentaire:
Enregistrer un commentaire